Fulltext

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort: reply

Yahya F 1 , Gaffney K 2 , Hamilton L 2 , Lonsdale E 2 , Leeder J 2 , Brooksby A 2 Show all authors , Cavill C 1 , Berry-Jenkins J 1 , Boyle C 1 , Bond D 1 , Sengupta R 1

Affiliations 

  • 1 Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UK
  • 2 Department of Rheumatology, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich
Rheumatol Adv Pract, 2018;2(2):rky037.
PMID: 31433399 DOI: 10.1093/rap/rky037

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications